• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用单克隆抗体修饰的牛血清白蛋白纳米颗粒靶向递送5-氟尿嘧啶

Targeted Delivery of 5-fluorouracil with Monoclonal Antibody Modified Bovine Serum Albumin Nanoparticles.

作者信息

Fadaeian Ghazal, Shojaosadati Seyed Abbas, Kouchakzadeh Hasan, Shokri Fazel, Soleimani Masoud

机构信息

Biotechnology Group, Chemical Engineering Faculty , Tarbiat Modares University, Tehran, Iran.

Department of Immunology, School of Public Health, Tehran University of Medical Science, Tehran, Iran. ; Monoclonal Antibody Research Center, Avicenna Research Institute, Tehran, Iran.

出版信息

Iran J Pharm Res. 2015 Spring;14(2):395-405.

PMID:25901146
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4403055/
Abstract

Herein, 1F2, an anti-HER2 monoclonal antibody (mAb), was covalently coupled to the surface of 5-Fluorouracil (5-FU) loaded bovine serum albumin (BSA) nanoparticles. Concerning two different crosslinkers for conjugation of 1F2, Maleimide-poly (ethylene glycol)-Succinimidyl carbonate (Mal-PEG5000-NHS) was selected due to its higher conjugation efficiency (23 ± 4%) obtained in comparison to N-succinimidyl 3-(2-Pyridyl Dithio) Propionate (SPDP) (8 ± 2%). A slight increase in the average particle size with a negligible prolongation of the 5-FU release was observed after 1F2 coupling. The 1F2-coupled 5-FU-loaded BSA nanoparticles interacted with nearly all HER2 receptors available on the surface of HER2-positive SKBR3 cells. No cellular uptake was observed for HER2-negative MCF7 cells. Physicochemical and biological properties of the mAb-modified nanoparticles did not significantly alter after three months of storage at room temperature. The in-vitro cytotoxicity evaluation by MTT assay, demonstrated lower SKBR3 viability (50.7 ± 9 %) after 5 hours contact with 1F2-coupled 5-FU-loaded BSA nanoparticles in comparison with the other control systems due to their cell attachment and internalization after washing. In addition, no significant toxicity was observed on MCF7 cells. This novel system can efficiently be employed for targeted delivery of 5-FU to HER2-positive cancerous cells.

摘要

在此,抗HER2单克隆抗体(mAb)1F2共价偶联至负载5-氟尿嘧啶(5-FU)的牛血清白蛋白(BSA)纳米颗粒表面。关于用于1F2偶联的两种不同交联剂,由于与N-琥珀酰亚胺基3-(2-吡啶基二硫代)丙酸酯(SPDP)相比,其获得了更高的偶联效率(23±4%),因此选择了马来酰亚胺-聚(乙二醇)-琥珀酰亚胺基碳酸酯(Mal-PEG5000-NHS)(8±2%)。在1F2偶联后,观察到平均粒径略有增加,而5-FU释放的延长可忽略不计。1F2偶联的负载5-FU的BSA纳米颗粒与HER2阳性SKBR3细胞表面几乎所有可用的HER2受体相互作用。未观察到HER2阴性MCF7细胞的细胞摄取。在室温下储存三个月后,mAb修饰的纳米颗粒的物理化学和生物学性质没有显著改变。通过MTT试验进行的体外细胞毒性评估表明,与其他对照系统相比,在与1F2偶联的负载5-FU的BSA纳米颗粒接触5小时后,SKBR3细胞活力较低(50.7±9%),这是由于洗涤后它们的细胞附着和内化。此外,未观察到对MCF7细胞有明显毒性。这种新型系统可有效地用于将5-FU靶向递送至HER2阳性癌细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e010/4403055/a0ac7636ebd5/ijpr-14-395-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e010/4403055/7cea08e002b7/ijpr-14-395-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e010/4403055/563fbfc801f8/ijpr-14-395-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e010/4403055/ab9915bfb99a/ijpr-14-395-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e010/4403055/d56983799209/ijpr-14-395-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e010/4403055/9970443a27c5/ijpr-14-395-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e010/4403055/a0ac7636ebd5/ijpr-14-395-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e010/4403055/7cea08e002b7/ijpr-14-395-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e010/4403055/563fbfc801f8/ijpr-14-395-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e010/4403055/ab9915bfb99a/ijpr-14-395-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e010/4403055/d56983799209/ijpr-14-395-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e010/4403055/9970443a27c5/ijpr-14-395-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e010/4403055/a0ac7636ebd5/ijpr-14-395-g006.jpg

相似文献

1
Targeted Delivery of 5-fluorouracil with Monoclonal Antibody Modified Bovine Serum Albumin Nanoparticles.用单克隆抗体修饰的牛血清白蛋白纳米颗粒靶向递送5-氟尿嘧啶
Iran J Pharm Res. 2015 Spring;14(2):395-405.
2
Optimization of an anti-HER2 monoclonal antibody targeted delivery system using PEGylated human serum albumin nanoparticles.采用聚乙二醇化人血清白蛋白纳米粒的抗 HER2 单克隆抗体靶向递药系统优化。
Int J Pharm. 2013 Apr 15;447(1-2):62-9. doi: 10.1016/j.ijpharm.2013.02.043. Epub 2013 Feb 27.
3
Attachment of an anti-MUC1 monoclonal antibody to 5-FU loaded BSA nanoparticles for active targeting of breast cancer cells.将抗MUC1单克隆抗体附着于负载5-氟尿嘧啶的牛血清白蛋白纳米颗粒,用于乳腺癌细胞的主动靶向。
Hum Antibodies. 2012;21(3-4):49-56. doi: 10.3233/HAB-2012-0261.
4
Investigation of an antitumor drug-delivery system based on anti-HER2 antibody-conjugated BSA nanoparticles.基于抗HER2抗体偶联牛血清白蛋白纳米颗粒的抗肿瘤药物递送系统的研究
Anticancer Drugs. 2018 Apr;29(4):307-322. doi: 10.1097/CAD.0000000000000586.
5
Synthesis and characterization of cystamine conjugated chitosan-SS-mPEG based 5-Fluorouracil loaded polymeric nanoparticles for redox responsive drug release.基于半胱胺接枝壳聚糖-SS-mPEG 的 5-氟尿嘧啶载药聚合物纳米粒的合成与表征及其氧化还原响应性药物释放。
Eur J Pharm Sci. 2018 Apr 30;116:37-47. doi: 10.1016/j.ejps.2017.10.035. Epub 2017 Nov 1.
6
Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.通过同时封装抗miR-21和5-氟尿苷的曲妥珠单抗偶联纳米颗粒增强胃癌治疗
Cell Physiol Biochem. 2017;44(6):2158-2173. doi: 10.1159/000485955. Epub 2017 Dec 12.
7
PLGA-PEG nanoparticles for targeted delivery of the mTOR/PI3kinase inhibitor dactolisib to inflamed endothelium.PLGA-PEG 纳米粒靶向递送达托利昔布(mTOR/PI3K 抑制剂)至炎症内皮。
Int J Pharm. 2018 Sep 15;548(2):747-758. doi: 10.1016/j.ijpharm.2017.10.032. Epub 2017 Oct 16.
8
Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells.隐形重组人血清白蛋白纳米粒偶联5-氟尿嘧啶增强了对人结肠癌HT-29细胞的药物递送和细胞毒性。
Colloids Surf B Biointerfaces. 2017 Jul 1;155:200-208. doi: 10.1016/j.colsurfb.2017.04.020. Epub 2017 Apr 12.
9
Albumin-Based Nanoparticles for the Delivery of Doxorubicin in Breast Cancer.用于乳腺癌中阿霉素递送的白蛋白基纳米颗粒
Cancers (Basel). 2021 Jun 16;13(12):3011. doi: 10.3390/cancers13123011.
10
Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.用于肿瘤靶向给药的基于壳聚糖接枝甲氧基聚乙二醇的细胞相容性载5-氟尿嘧啶聚合物纳米粒
Drug Dev Ind Pharm. 2018 Mar;44(3):365-376. doi: 10.1080/03639045.2017.1371741. Epub 2017 Dec 5.

引用本文的文献

1
Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy.用于奥沙利铂癌症治疗的位点特异性递送的纳米结构:协同癌症治疗中的多功能纳米平台。
Transl Oncol. 2024 Jan;39:101838. doi: 10.1016/j.tranon.2023.101838. Epub 2023 Nov 27.
2
Synthesis and Optimization of the Docetaxel-Loaded and Durvalumab-Targeted Human Serum Albumin Nanoparticles, In Vitro Characterization on Triple-Negative Breast Cancer Cells.多西他赛负载及度伐利尤单抗靶向的人血清白蛋白纳米粒的合成与优化:三阴性乳腺癌细胞的体外表征
ACS Omega. 2023 Jul 13;8(29):26287-26300. doi: 10.1021/acsomega.3c02682. eCollection 2023 Jul 25.
3

本文引用的文献

1
Docetaxel Loaded PEG-PLGA Nanoparticles: Optimized Drug Loading, In-vitro Cytotoxicity and In-vivo Antitumor Effect.多西他赛负载的聚乙二醇-聚乳酸-羟基乙酸共聚物纳米粒:优化的载药量、体外细胞毒性及体内抗肿瘤作用
Iran J Pharm Res. 2014 Summer;13(3):819-33.
2
Production and Quality Control of [(67)Ga]-DOTA-trastuzumab for Radioimmunoscintigraphy.用于放射免疫闪烁显像的[(67)Ga]-DOTA-曲妥珠单抗的生产与质量控制
Iran J Pharm Res. 2013 Spring;12(2):355-66.
3
Attachment of an anti-MUC1 monoclonal antibody to 5-FU loaded BSA nanoparticles for active targeting of breast cancer cells.
Recent trends in protein and peptide-based biomaterials for advanced drug delivery.
近年来用于高级药物输送的蛋白质和肽基生物材料的趋势。
Adv Drug Deliv Rev. 2020;156:133-187. doi: 10.1016/j.addr.2020.08.008. Epub 2020 Aug 29.
4
In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy.用于肝细胞癌化疗的大分子前药GC-FUA纳米颗粒的体外和体内评价
Drug Deliv. 2017 Nov;24(1):459-466. doi: 10.1080/10717544.2016.1264499.
5
Use of single chain antibody derivatives for targeted drug delivery.单链抗体衍生物在靶向药物递送中的应用。
Mol Med. 2016 Sep;22:258-270. doi: 10.2119/molmed.2016.00043. Epub 2016 Apr 22.
将抗MUC1单克隆抗体附着于负载5-氟尿嘧啶的牛血清白蛋白纳米颗粒,用于乳腺癌细胞的主动靶向。
Hum Antibodies. 2012;21(3-4):49-56. doi: 10.3233/HAB-2012-0261.
4
Optimization of an anti-HER2 monoclonal antibody targeted delivery system using PEGylated human serum albumin nanoparticles.采用聚乙二醇化人血清白蛋白纳米粒的抗 HER2 单克隆抗体靶向递药系统优化。
Int J Pharm. 2013 Apr 15;447(1-2):62-9. doi: 10.1016/j.ijpharm.2013.02.043. Epub 2013 Feb 27.
5
Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances.靶向受体介导的内吞途径的纳米颗粒:原理和进展。
Adv Drug Deliv Rev. 2013 Jan;65(1):121-38. doi: 10.1016/j.addr.2012.09.041. Epub 2012 Sep 29.
6
Albumin nanoparticles with predictable size by desolvation procedure.通过去溶剂化程序制备具有可预测尺寸的白蛋白纳米颗粒。
J Microencapsul. 2012;29(2):138-46. doi: 10.3109/02652048.2011.635218.
7
Impact of albumin on drug delivery--new applications on the horizon.白蛋白对药物传递的影响--新的应用前景。
J Control Release. 2012 Jan 10;157(1):4-28. doi: 10.1016/j.jconrel.2011.09.069. Epub 2011 Sep 16.
8
Characterization of novel murine monoclonal antibodies directed against the extracellular domain of human HER2 tyrosine kinase receptor.针对人HER2酪氨酸激酶受体细胞外结构域的新型鼠源单克隆抗体的特性分析
Hybridoma (Larchmt). 2011 Aug;30(4):347-53. doi: 10.1089/hyb.2011.0023.
9
Albumin-based nanoparticles as potential controlled release drug delivery systems.白蛋白纳米粒作为潜在的控制释放药物传递系统。
J Control Release. 2012 Jan 30;157(2):168-82. doi: 10.1016/j.jconrel.2011.07.031. Epub 2011 Aug 1.
10
Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting.载紫杉醇牛血清白蛋白纳米粒的设计与研制及其脑靶向性研究
Acta Pharm. 2011 Jun;61(2):141-56. doi: 10.2478/v10007-011-0012-8.